The company has improved its financial position by expanding its equity base to $663.5 million in 2026Q3, up from a low of $269.4 million in 2025Q1.
SelectQuote, Inc. (SLQT) balance sheet — 9-year assets, liabilities & shareholders' equity history
| Metric | TTM | Jun'26 | Jun'25 | Jun'24 | Jun'23 | Jun'22 | Jun'21 | Jun'20 | Jun'19 | Jun'18 |
|---|
| Total Assets | 1.25B | 1.52B | 1.25B | 1.19B | 1.22B | 1.29B | 1.42B | 1.13B | 406.94M | 297.56M |
| Asset Growth % | 34.18% | 21.74% | 4.64% | -2.08% | -5.49% | -9.4% | 26.22% | 177.2% | 36.76% | - |
| Total Investment Assets | 4M | 853.63M | 820.08M | 723.97M | 0 | 0 | 0 | 461.75M | 279.49M | 196.09M |
| Long-Term Investments | 3.39B | 853.63M | 820.08M | 723.97M | 0 | 0 | 0 | 461.75M | 279.49M | 196.09M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 365.99M | 350.95M | 341.04M | 332.92M | 363.22M | 402.77M | 483.42M | 513.83M | 102.96M | 83.57M |
| Cash & Equivalents | 13.44M | 20.72M | 32.4M | 42.69M | 83.16M | 141M | 286.45M | 368.87M | 570K | 958K |
| Receivables | 1.33B | 305.55M | 283.46M | 270.89M | 267.44M | 248.08M | 194.47M | 136.88M | 95.94M | 79.02M |
| Other Current Assets | 22.18M | 24.68M | 25.18M | 5.03M | 0 | 0 | 0 | 828K | 6.45M | 3.59M |
| Goodwill & Intangibles | 157M | 30.28M | 46.47M | 53.61M | 54.08M | 76.69M | 121.3M | 74.65M | 10.26M | 6.29M |
| Goodwill | 29.44M | 29.44M | 29.44M | 29.44M | 29.14M | 29.14M | 68.02M | 46.58M | 5.36M | 5.36M |
| Intangible Assets | 18.93M | 839K | 17.03M | 24.17M | 24.94M | 47.56M | 53.28M | 28.07M | 4.89M | 929K |
| PP&E (Net) | 30.32M | 32.56M | 39.21M | 42.41M | 51.02M | 69.82M | 60.92M | 22.15M | 13.76M | 11.08M |
| Other Assets | 1.15M | 253.56M | 2.55M | 41M | 750.94M | 740.77M | 758.21M | 1.41M | 279.96M | 196.62M |
| Total Liabilities | 620.65M | 870.96M | 673.84M | 877.11M | 872.28M | 898.95M | 756.82M | 582.36M | 143.69M | 109.63M |
| Total Debt | 410.88M | 396.37M | 415.91M | 713.92M | 731.8M | 745.06M | 505.3M | 311.92M | 25.68M | 19.83M |
| Net Debt | 397.44M | 375.65M | 383.51M | 671.23M | 648.64M | 604.07M | 218.84M | -56.95M | 25.11M | 18.87M |
| Long-Term Debt | 364.25M | 348.15M | 316.59M | 637.48M | 664.63M | 698.42M | 459.04M | 311.81M | 21.65M | 19.75M |
| Short-Term Debt | 25.84M | 22.01M | 68.52M | 45.85M | 33.88M | 7.17M | 2.36M | 49K | 3.92M | 0 |
| Total Current Liabilities | 183.32M | 192.62M | 212.91M | 174.59M | 137.26M | 113.51M | 108.82M | 95.81M | 33.22M | 24.28M |
| Accounts Payable | 59.19M | 74.03M | 59.2M | 36.59M | 27.58M | 24.77M | 34.08M | 22.89M | 7.63M | -33K |
| Deferred Revenue | 0 | 0 | 698K | 12.72M | 2.83M | 8.03M | 5.08M | 1.74M | 2.02M | 3.3M |
| Other Current Liabilities | 98.3M | 92.13M | 65.81M | 16.99M | 50.67M | 42.15M | 41.15M | 48.91M | 1.33M | 1.31M |
| Deferred Taxes | 176.83M | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Liabilities | 12.2M | 23.79M | 80.48M | 1.81M | 2.83M | 2.86M | 11.72M | 14.58M | 7.49M | 5.94M |
| Total Equity | 631.34M | 650.02M | 575.52M | 316.8M | 346.97M | 391.11M | 667.04M | 545.69M | 263.25M | 187.93M |
| Equity Growth % | 137.4% | 12.95% | 81.67% | -8.7% | -11.28% | -41.37% | 22.24% | 107.29% | 40.08% | - |
| Shareholders Equity | 631.34M | 650.02M | 575.52M | 316.8M | 346.97M | 391.11M | 667.04M | 545.69M | 263.25M | 187.93M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | -180.3M | -160M | -222.19M | -269.77M | -235.64M | -177.1M | 120.4M | -2.79M | 200.45M | 129.47M |
| Common Stock | 1.79M | 1.76M | 1.73M | 1.69M | 1.67M | 1.64M | 1.64M | 1.62M | 1.15M | 1.1M |
| Accumulated OCI | 0 | 0 | 0 | 4.11M | 13.68M | 11.72M | 229K | -1.25M | 0 | -10.26M |
| Return on Equity (ROE) | 11.28% | 10.15% | 10.66% | -10.28% | -15.86% | -56.23% | 20.59% | 19.65% | 32.17% | 18.57% |
| Return on Assets (ROA) | 5.3% | 4.49% | 3.89% | -2.83% | -4.67% | -21.92% | 9.79% | 10.36% | 20.6% | 11.73% |
| Equity / Assets | 50.43% | 42.74% | 46.07% | 26.53% | 28.46% | 30.32% | 46.85% | 48.37% | 64.69% | 63.16% |
| Debt / Equity | 0.65x | 0.61x | 0.72x | 2.25x | 2.11x | 1.91x | 0.76x | 0.57x | 0.10x | 0.11x |
| Book Value per Share | 3.30 | 3.45 | 3.16 | 1.88 | 2.09 | 2.38 | 4.03 | 3.36 | 1.62 | 1.36 |
| Tangible BV per Share | 3.04 | 3.29 | 2.91 | 1.56 | 1.76 | 1.92 | 3.30 | 2.90 | 1.56 | 1.31 |
Quick answers to the most common questions about buying SLQT stock.
As of 2026, SelectQuote, Inc. (SLQT) had total assets of $1.52B including $350.9M in current assets.
SelectQuote, Inc. (SLQT) carries total debt of $396.4M, offset by $20.7M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
SelectQuote, Inc. (SLQT) has total shareholders' equity (book value) of $650.0M ($3.45 book value per share). Book value represents the net worth of the company belonging to common stock holders.
SelectQuote, Inc. (SLQT) reported a current ratio of 1.82x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
CMS Regulatory Marketing Compliance
Metrics are mathematically derived from official filings.
Equity Base Shows Recent Recovery
As reported in financial statements, SelectQuote's equity base expanded to $663.5 million in 2026Q3 from a low of $269.4 million in 2025Q1, suggesting a stabilization in the firm's capital position despite the inherent volatility associated with its Medicare-focused business model and seasonal enrollment cycles.
The significant improvement in equity over the last six quarters indicates a successful effort to repair the balance sheet following periods of intense capital strain. Investors should monitor whether this growth is sustainable or if it remains vulnerable to future shifts in policy retention and LTV revisions.
Claims Volatility Reflects Operational Risk
Based on historical figures, the company's claims and loss reserves reached a peak of $261.9 million in 2026Q1, highlighting the substantial liability exposure that accompanies the firm's aggressive pursuit of market share within the highly competitive and regulated Medicare Advantage distribution landscape.
The fluctuation in loss reserves suggests that the company faces unpredictable claims-related obligations that can rapidly impact liquidity. This volatility warrants further investigation into the adequacy of these reserves relative to the long-term persistence of the policies being sold.
Deleveraging Enhances Strategic Financial Flexibility
According to recent SEC filings, the company has successfully reduced its total liabilities from $953.2 million in 2025Q2 to $671.2 million in 2026Q3, which appears to provide the firm with greater strategic flexibility to navigate ongoing regulatory headwinds and potential shifts in lead acquisition costs.
The reduction in total liabilities relative to the equity base suggests a more conservative approach to capital management compared to prior periods. This shift may indicate that management is prioritizing balance sheet stability over the aggressive, debt-fueled expansion strategies that characterized earlier fiscal years.
Accounting Estimates Mask Underlying Liabilities
Data from the last ten quarters indicates that the reliance on ASC 606 revenue recognition for lifetime value estimates may obscure the true cash-generating capacity of the business, as evidenced by the significant divergence between reported equity growth and the underlying operational performance of the firm.
The reliance on non-cash revenue recognition creates a disconnect between the balance sheet's reported health and the actual liquidity available to meet claims. Investors should be cautious, as these accounting estimates may not fully reflect the potential for future revenue clawbacks if policy churn exceeds current management projections.